The significant reductions in serum concentrations of PD-L1, IL-1ra, and CCL4 suggest potential benefits of the intervention for obesity, with implications in many diseases such as diabetes, cancer, and autoimmune conditions. This evidence concerns the gene CCL4 and diabetes mellitus.